Search

1 article for “beta-thalassaemia”

• Published Subscription 6 May 2016

  Desferrioxamine-induced Ototoxicity (SNHL) in β-Thalassaemia

  By C. Pandu Varaprasad, Nrithya S. Kumar, Anakha Thyag, M. Venkata Subbaiah

  Abstract: Thalassaemia is a hereditary disorder requiring regular blood transfusion. The repeated transfusion results in an iron overload state with succeeding complications. Iron chelation therapy with desferrioxamine removes excess iron and its prolonged usage causes ototoxicity. This is a rare disease observed in the ENT (OP) Department, Rajiv Gandhi Institute of Medical Sciences (RIMS) [a 750 bedded tertiary teaching hospital], Kadapa, AP, India. A 12-year-old female patient was presented with complains …

  Published in Research and Reviews: A Journal of Pharmacology · Vol. 6, Issue 1, 2016 · pp. 10–12 Read article →